Business Context and Reporting Period
Company: Lifecore Biomedical, Inc. (LFCR)
Filing Type: Form 8-K (Current Report)
Date of Report: August 26, 2024
Reporting Period: Fourth quarter and full year of fiscal 2024 ended May 26, 2024.
Key Financial Metrics
The provided filing text serves as a notification of results and does not contain specific numerical data. The filing states that consolidated financial results for the fourth quarter and full year of fiscal 2024 were announced via a press release furnished as Exhibit 99.1. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It references the press release (Exhibit 99.1) for the announcement of results but does not summarize the variances within the body of this 8-K.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. It explicitly notes that the information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 26, 2024) for actual revenue, net income, and EPS figures.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check the press release for any updated fiscal 2025 guidance or outlook.
- Confirm liquidity positions and debt covenants in the detailed financial statements referenced in the press release.